Navigation Links
New Conflict of Interest Violations Revealed at California Stem Cell Institute

Tainted Research Grant Applications Must Be Rejected, Consumer Advocates Say

SANTA MONICA, Calif., Dec. 7 /PRNewswire-USNewswire/ -- More apparent conflict of interest violations in applications for research grants in California's $6 billion stem cell program were revealed today and the Foundation for Taxpayer and Consumer Rights (FTCR) called for all the tainted applications to be rejected.

The latest improprieties were reported by the San Francisco Chronicle and came in the wake of the revelation that John Reed, Burnham Institute president and stem cell board member, had lobbied to reverse the rejection of a grant to his institution. Read the Chronicle story here: TL&feed=rss.bayarea

The new violations of stem cell board ethics rules came when some university deans who also serve on the stem cell board wrote letters supporting applications for research grants. The grants in question could total $3 million each over five years. During its meeting in Los Angeles next week, the stem cell board plans to award up to $85 million for the grants which are aimed at faculty members just starting their independent research careers.

Applications from UC San Diego, UC San Francisco, UC Los Angeles and the University of Southern California were reported to be affected.

"It's simple: stem cell board members cannot take part in any way in grants to their institutions," said John M. Simpson, FTCR's Stem Cell Project Director. "The board is not some old-boy's club for the benefit of the state's universities. They are public officials and stewards of the public interest. Perhaps a few of these deans need to enroll in Ethics 101 at their universities and get the basics down."

FTCR said that the tainted applications must be thrown out. To do otherwise would be unfair to all those who acted correctly. For instance, Dr. Philip Pizzo, dean of the Stanford University School of Medicine, told the Chronicle: "I can only say that as a member of the (stem cell governing board), I am well aware that I must recuse myself from any grant application, proposal or action related to Stanford or any other individual or setting where I could have a conflict of interest."

FTCR has filed a complaint with the Fair Political Practices Commission (FPPC) about the Reed incident and called for both him and stem cell chairman Robert Klein to resign. Stem cell board members Jeff Sheehy and David Serrano Sewell have also called for Reed to step down from the board. State Controller John Chiang has announced plans to audit the agency and asked the FPPC to investigate.

The latest improprieties, though serious, are not as egregious as the Reed affair, FTCR said. The agency's call for applications asked for a letter of support either from the dean or department chairman. "Board members have signed conflict of interest rules and clearly should know what's right and what they can do," said Simpson. "However, this is not the same flagrant violation as actively lobbying to overturn a decision. Throwing out the tainted applications should be an adequate punishment."

FTCR also said that the stem cell committee should discuss at its meeting Wednesday what penalties are right for violations of its rules by board members. "They've got all these supposed rules that Chairman Klein likes to call 'the gold-standard,' but they are absolutely meaningless unless there are consequences when they are broken," said Simpson.

Proposition 71, passed by 59 percent of Californians in 2004, created an oversight board fraught with potential conflicts of interest. "Most of the people handing out the money are the very same people from the institutions that get the money," said Simpson. "That means the conflict rules in place must be strictly adhered to and there must be consequences when they are violated. 'Golly, we meant well and will do better next time' simply does not cut it."

FTCR's Stem Cell Oversight and Accountability Project is working to ensure that California's landmark stem cell research program offers accessible and affordable cures and treatments to the taxpayers who have funded it. The program will award $3 billion in grants over a decade. Bond financing charges mean the project, the largest source of stem cell research funding in the world, will cost California taxpayers $6 billion.

The Foundation for Taxpayer and Consumer Rights is California's leading non-profit and non-partisan consumer watchdog group. For more information visit us on the web at:

SOURCE Foundation for Taxpayer and Consumer Rights
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Saving Lives of California Residents Who Develop Skin Cancer Each Year: The Key is Early Detection and Treatment
2. California Legislature Passes Historic HIV Testing Bill (AB 682); AHF Urges Governor to Sign Crucial Lifesaving Legislation
3. Veto of Californias Condoms in Prisons Bill: "Politics Over Public Health," Says AHF
4. Tezampanel, TorreyPines Therapeutics Lead Compound, Reduced Muscle Spasticity and Rigidity in Preclinical Study Conducted at University of California, San Diego
5. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
6. Sports Legacy Institute Announces Findings of Forensic Examinations on Wrestler Chris Benoits Brain
7. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
8. Spine Institute of Louisiana Offers Cervical Spine Motion Preservation as an Alternative to Fusion Surgery
9. Trana Discovery and Southern Research Institute Announce the First RNA-RNA High Throughput Drug Screening Assay Platform for HIV Antivirals
10. Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies
11. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
Post Your Comments:
(Date:12/1/2015)... Dec. 1, 2015  Lexicon Pharmaceuticals, Inc. ... top-line data from its TELECAST Phase 3 ... treating carcinoid syndrome in cancer patients with ... benefit observed in its pivotal TELESTAR study.  ... companion to TELESTAR primarily to provide additional ...
(Date:12/1/2015)... , Dec. 1, 2015  ImmunoCellular Therapeutics, ... Andrew Gengos , President and Chief ... on December 3, 2015. Mr. Gengos plans ... registrational program in patients with newly diagnosed ... TIME:    12:15p.m. ET/9:15a.m. PT LINK: ...
(Date:12/1/2015)... and UPPSALA, Sweden , December ... been selected by the International Breast Cancer Study Group (IBCSG, ... (BIG, Brussels ) to be part of ... palbociclib, a promising new cancer drug.  --> ... women with advanced breast cancer being treated with anti-hormonal therapy ...
Breaking Medicine Technology:
(Date:12/1/2015)... PA (PRWEB) , ... December 01, 2015 , ... ... imaging facilities, radiographic technicians must mark the film for accurate interpretation by the ... track of. Fortunately, an inventor from Sacramento, Calif., has found a way to ...
(Date:12/1/2015)... ... 2015 , ... McLean, VA., December 1, 2015 - Octo ... sprint agile development contract to support the National Geospatial-Intelligence Agency's (NGA) IT Services ... engineering, infrastructure, as well as operations and sustainment support to the NGA’s Agile ...
(Date:12/1/2015)... ... December 01, 2015 , ... PartnerTech , ... membership and leadership since 2008. Gary Bruce, President of PartnerTech North America, currently ... spent a significant amount of time in Sweden since joining PartnerTech based in ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... Center Enterprise Authorized Technology Provider (ATP) status from Cisco. This designation recognizes Tympani ... support Cisco Unified Contact Center solutions targeted to the high-end enterprise contact center ...
(Date:11/30/2015)... NY (PRWEB) , ... December 01, 2015 , ... ... honors Christina Colon as a 2015-2016 inductee into its VIP Woman ... in pharmacy. NAPW is the nation’s leading networking organization exclusively for professional women, ...
Breaking Medicine News(10 mins):